The Antitrust Division of the U.S. Department of Justice gave pharmaceutical giants including Eli Lilly & Co., Amgen Inc. and GlaxoSmithKline PLC a green light on Thursday for limited sharing of information about a possible treatment for COVID-19…
Read this piece in its entirety at Law360.